Until that completes and regulators review it, retatrutide remains investigational, with no marketing authorization, no licensed supply, and no approved labeling defining who it is for or how it should be used
Urick said discontinuation can be attributed to five common causes, of which side effects are only one, along with affordability, availability, physician drug switches and the achievement of weight loss goals
Large randomized controlled trials, including the STEP trials, demonstrated consistent weight loss of 15-22% over 68 weeks using the standard once-weekly dosing protocol starting at 0.25 mg and titrating to 2.4 mg
Hair loss is so common in men, that a B12 deficiency as the cause of it is often missed
This article describes cardiovascular considerations related to COVID-19 and highlights gaps in knowledge that require further study pertinent to patients, health-care workers and health systems
Liczby (20,9%, 3,1%) opisuj profil klasy w pimiennictwie nie spodziewany wynik odczynnika